Chemoinformaics analysis of 3, 8-Dimethoxy-4, 5, 7- Trihydroxyflavone
| Molecular Weight | 330.292 | nRot | 3 |
| Heavy Atom Molecular Weight | 316.18 | nRig | 18 |
| Exact Molecular Weight | 330.074 | nRing | 3 |
| Solubility: LogS | -3.831 | nHRing | 1 |
| Solubility: LogP | 2.76 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 43.3391 |
| nHD | 3 | BPOL | 20.1209 |
| QED | 0.677 |
| Synth | 2.51 |
| Natural Product Likeliness | 1.569 |
| NR-PPAR-gamma | 0.933 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.821 |
| Pgp-sub | 0.001 |
| HIA | 0.032 |
| CACO-2 | -4.897 |
| MDCK | 0.0000133 |
| BBB | 0.007 |
| PPB | 0.932661 |
| VDSS | 0.689 |
| FU | 0.110882 |
| CYP1A2-inh | 0.942 |
| CYP1A2-sub | 0.908 |
| CYP2c19-inh | 0.279 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.74 |
| CYP2c9-sub | 0.898 |
| CYP2d6-inh | 0.513 |
| CYP2d6-sub | 0.272 |
| CYP3a4-inh | 0.489 |
| CYP3a4-sub | 0.154 |
| CL | 7.508 |
| T12 | 0.88 |
| hERG | 0.017 |
| Ames | 0.698 |
| ROA | 0.293 |
| SkinSen | 0.524 |
| Carcinogencity | 0.174 |
| EI | 0.897 |
| Respiratory | 0.131 |
| NR-Aromatase | 0.91 |
| Antiviral | Yes |
| Prediction | 0.779363 |